(Q37888721)

24 August 2017

1 reference

title

Complications of thalassemia major and their treatment (English)

1 reference

24 August 2017

1 reference

Caterina Borgna-Pignatti

series ordinal

1

1 reference

24 August 2017

Maria Rita Gamberini

series ordinal

2

1 reference

24 August 2017

publication date

1 June 2011

1 reference

Expert Review of Hematology

24 August 2017

published in

1 reference

24 August 2017

volume

4

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

353-366

1 reference

24 August 2017

1 reference

Hepcidin and disorders of iron metabolism

21 January 2018

1 reference

Labile plasma iron in iron overload: redox activity and susceptibility to chelation

21 January 2018

1 reference

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

21 January 2018

1 reference

Action of chelators in iron-loaded cardiac cells: Accessibility to intracellular labile iron and functional consequences

21 January 2018

1 reference

Rapid desensitisation for desferrioxamine anaphylactoid reaction.

21 January 2018

1 reference

Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosage

21 January 2018

1 reference

Ocular changes in patients undergoing long-term desferrioxamine treatment

21 January 2018

1 reference

Visual loss in patient on high-dose subcutaneous desferrioxamine

21 January 2018

1 reference

A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia

21 January 2018

1 reference

Thalassemia major 1995: older patients, new therapies

21 January 2018

1 reference

Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study.

21 January 2018

1 reference

Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major

21 January 2018

1 reference

Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance

21 January 2018

1 reference

Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance

21 January 2018

1 reference

Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overload

21 January 2018

1 reference

The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores

21 January 2018

1 reference

Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.

21 January 2018

1 reference

Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone

21 January 2018

1 reference

Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone

21 January 2018

1 reference

Relation of chelation regimes to cardiac mortality and morbidity in patients with thalassaemia major: an observational study from a large Greek Unit

21 January 2018

1 reference

High frequency of hepatitis B virus infection in patients with beta-thalassemia receiving multiple transfusions

21 January 2018

1 reference

Hepatitis-C-virus genotypes and hepatitis-G-virus infection in Lebanese thalassaemics

21 January 2018

1 reference

Transient elastography in the assessment of liver fibrosis in adult thalassemia patients

21 January 2018

1 reference

Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) â lack of interference by iron deposition

21 January 2018

1 reference

Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.

21 January 2018

1 reference

Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

21 January 2018

1 reference

MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients

21 January 2018

1 reference

Magnetic resonance imaging measurement of iron overload

21 January 2018

1 reference

Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection

21 January 2018

1 reference

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

Hepatocellular carcinoma in the thalassaemia syndromes

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

21 January 2018

1 reference

Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel.

21 January 2018

1 reference

Safety and efficacy of pegylated interferon alpha-2a and ribavirin for the treatment of hepatitis C in patients with thalassemia

21 January 2018

1 reference

Predicting pituitary iron and endocrine dysfunction

21 January 2018

1 reference

Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients

21 January 2018

1 reference

Complications of beta-thalassemia major in North America

21 January 2018

1 reference

Pregnancy and beta-thalassemia: an Italian multicenter experience.

21 January 2018

1 reference

Assessment of thyroid function in two hundred patients with beta-thalassemia major

21 January 2018

1 reference

Longitudinal study on thyroid function in patients with thalassemia major.

21 January 2018

1 reference

Primary hypothyroidism and the low T3 syndrome in thalassaemia major

21 January 2018

1 reference

Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major

21 January 2018

1 reference

Hypoparathyroidism in beta-thalassemia major. Clinical and laboratory observations in 24 patients

21 January 2018

1 reference

Hypoparathyroidism in transfusion-dependent patients with beta-thalassemia

21 January 2018

1 reference

Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion.

21 January 2018

1 reference

Chronic hepatitis C virus infection without cirrhosis induces insulin resistance in patients with alpha-thalassaemia major

21 January 2018

1 reference

HLA-A, B, C, and DR antigen frequencies in relation to development of diabetes and variations in white cell antibody formation in highly transfused thalassemia patients

21 January 2018

1 reference

Growth of Children with Thalassaemia: Effect of Different Transfusion Regimens

21 January 2018

1 reference

Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major

21 January 2018

1 reference

Growth deficiency in polytransfused beta-thalassaemia patients is not growth hormone dependent.

21 January 2018

1 reference

Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment

21 January 2018

1 reference

Growth and factors affecting it in thalassemia major

21 January 2018

1 reference

Growth hormone secretion in adult patients with thalassaemia

21 January 2018

1 reference

The pituitary-adrenal axis in adult thalassaemic patients.

21 January 2018

1 reference

Predisposing factors for adrenal insufficiency

21 January 2018

1 reference

Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America

21 January 2018

1 reference

Osteoporosis in beta-thalassemia: Clinical and genetic aspects

21 January 2018

1 reference

High prevalence of low bone mass in thalassaemia major

21 January 2018

1 reference

Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle

21 January 2018

1 reference

Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis

21 January 2018

1 reference

21 January 2018

1 reference

Calcium plus vitamin D supplementation and the risk of fractures

21 January 2018

1 reference

Teriparatide, osteoporosis, calcium, and vitamin D.

21 January 2018

1 reference

Strontium ranelate: the first agent of a new therapeutic class in osteoporosis

21 January 2018

1 reference

Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update.

21 January 2018

1 reference

Aneurysmatic dilatation of ascending aorta in a patient with beta-thalassemia and a pseudoxanthoma elasticum-like syndrome.

21 January 2018

1 reference

Cardiovascular involvement in thalassaemic patients with pseudoxanthoma elasticum-like skin lesions: a long-term follow-up study

21 January 2018

1 reference

Magnesium carbonate-containing phosphate binder prevents connective tissue mineralization in Abcc6(-/-) mice-potential for treatment of pseudoxanthoma elasticum

21 January 2018

1 reference

The hypercoagulable state in thalassemia

21 January 2018

1 reference

Redefining thalassemia as a hypercoagulable state

21 January 2018

1 reference

Infections and thalassaemia

21 January 2018

1 reference

Effects of chelators (deferoxamine, deferiprone and deferasirox) on the growth of Klebsiella pneumoniae and Aeromonas hydrophila isolated from transfusion-dependent thalassemia patients.

21 January 2018

1 reference

Asplenic-hyposplenic overwhelming sepsis: postsplenectomy sepsis revisited

21 January 2018

1 reference

Cholelithiasis in thalassemia major

21 January 2018

1 reference

Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia

21 January 2018

1 reference

New and experimental therapies for HCV.

21 January 2018

1 reference

Growth hormone reserve in adult beta thalassemia patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EHM.11.29

1 reference

24 August 2017

1 reference